Details for 2018848036
Up to date per 01.04.2026
Actions
Details for 2018848036
Granted/Registered
European Patent
01.07.2020 A
18.10.2023 B1
25.08.2017
US
201762550462 P
23.10.2017
US
201762575901 P
04.05.2018
US
201862667356 P
15.05.2018
US
201862671745 P
C12N 15/11 20060101AFI20210409BHEP
Owner
Stoke Therapeutics, Inc.45 Wiggins Avenue Bedford, MA 01730US
Representative
Authorized Recipients
Paul CosmoviciGumpendorfer Straße 1421060 WienAT
Inventor
AZNAREZ, Isabel196 Chestnut Avenue Unit B Boston Massachusetts 02130US
HAN, Zhou110 North Avenue Natick Massachusetts 01760US
Information about Fees